Product/Composition:- | Ondansetron tablets |
---|---|
Strength:- | 4 mg, 8 mg |
Form:- | Tablet |
Reference Brands:- | Zofran(US & EU) |
MOQ | As per the manufacturer batch size |
Get Quote Send Enquiry on WhatsApp |
Ondansetron tablets are 5-HT3 receptor antagonists that block serotonin receptors in the gastrointestinal tract and brain, preventing nausea and vomiting. They are commonly used during chemotherapy, radiation, or postoperative care, providing effective relief from nausea, improving patient comfort, and preventing dehydration and fatigue associated with vomiting.
Ondansetron tablets are approved in both the US and EU, supported by comprehensive dossiers demonstrating safety, efficacy, and manufacturing quality compliant with GMP standards. In the US, Zofran (by GlaxoSmithKline) is a widely used branded product, while in the EU, ondansetron is available as both branded and generic formulations. Regulatory approval involves rigorous clinical and safety evaluations, and detailed dossiers ensure product quality. For more information on licensing, approved dossiers, and regulatory requirements for ondansetron tablets, visit Pharmatradz. Stay informed on the latest approval processes and market access regulations for ondansetron worldwide.